Guardian Wealth Management, Inc. Astrazeneca PLC Transaction History

Guardian Wealth Management, Inc.

$132 Million
Q4 2024

A detailed history of Guardian Wealth Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Guardian Wealth Management, Inc. holds 4,454 shares of AZN stock, worth $327,369. This represents 0.22% of its overall portfolio holdings.

Number of Shares

4,454

Previous 4,454 -0.0%

Holding current value

$327,369

Previous $347,000 16.14%

% of portfolio

0.22%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $460 - $525	6 Added 0.13%	4,454 $347,000
Q2 2024 Aug 08, 2024	SELL	$66.81 - $80.83 $1,670 - $2,020	-25 Reduced 0.56%	4,448 $346,000
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $19,712 - $22,471	-323 Reduced 6.73%	4,473 $303,000
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $20,114 - $22,516	-325 Reduced 6.35%	4,796 $323,000
Q3 2023 Oct 31, 2023	SELL	$64.85 - $71.7 $369,191 - $408,188	-5,693 Reduced 52.64%	5,121 $346,000
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $978 - $1,061	-14 Reduced 0.13%	10,814 $773,000
Q1 2023 May 09, 2023	SELL	$63.15 - $71.6 $3,662 - $4,152	-58 Reduced 0.53%	10,828 $751,000
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $7,047 - $9,157	-130 Reduced 1.18%	10,886 $738,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $2,651 - $6,787	50 Added 0.46%	11,016 $604,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $2,429 - $2,916	41 Added 0.38%	10,966 $724,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $12,425 - $14,967	223 Added 2.08%	10,925 $725,000
Q4 2021 Feb 15, 2022	BUY	$54.02 - $63.83 $578,122 - $683,108	10,702 New	10,702 $623,000

Others Institutions Holding AZN

# of Institutions

1,364

Shares Held

476M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Management, Inc. with notifications on news.

Account

Guardian Wealth Management, Inc. Astrazeneca PLC Transaction History